0GRZ.LSE RaySearch Laboratories AB ser. B

Healthcare Commercial Services & Supplies London Exchange
- SEK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
0.50%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is 0GRZ.LSE undervalued?

Graham number

The Graham number of RaySearch Laboratories AB ser. B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RaySearch Laboratories AB ser. B fundamental analysis

No fundamental analysis for RaySearch Laboratories AB ser. B yet.

RaySearch Laboratories AB ser. B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RaySearch Laboratories AB ser. B

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning a…

Full company profile